Icon (ICLR) Accumulated Expenses (2009 - 2025)
Icon's (ICLR) quarterly Accumulated Expenses came in at $894.4 million in Q4 2025, up 1.57% year-over-year from $880.7 million in Q4 2024, and up 1.57% quarter-over-quarter from $880.7 million in Q4 2024.
Analysis
Icon (ICLR) Accumulated Expenses (2009 - 2025) Analysis & Trends
Icon (ICLR) has reported Accumulated Expenses for 17 consecutive years, with $894.4 million the latest figure, recorded in Q4 2025.
- On a quarterly basis, Accumulated Expenses rose 1.57% year-over-year to $894.4 million in Q4 2025; TTM through Dec 2025 was $894.4 million, a 1.57% increase from a year earlier, with the FY2025 full-year figure at $894.4 million, up 1.57% from the prior year.
- Accumulated Expenses was $894.4 million for Q4 2025 at Icon, up from $880.7 million in the prior quarter.
- Over five years, Accumulated Expenses peaked at $999.5 million in Q4 2022 and troughed at -$388.4 million in Q1 2021.
- A 5-year average of $707.2 million and a median of $902.4 million in 2023 frame the typical range for Accumulated Expenses.
- Across the five-year window, Accumulated Expenses jumped 141.12% in 2021 and retreated 8.91% in 2023, its largest moves.
- Over 5 years, Accumulated Expenses stood at $946.5 million in 2021, then advanced by 5.6% to $999.5 million in 2022, then fell by 8.91% to $910.4 million in 2023, then slipped by 3.27% to $880.7 million in 2024, then increased by 1.57% to $894.4 million in 2025.
- The last three Accumulated Expenses figures came in at $894.4 million (Q4 2025), $880.7 million (Q4 2024), and $910.4 million (Q4 2023), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 894.44 Mn |
| Dec 31, 2024 | 880.66 Mn |
| Dec 31, 2023 | 910.45 Mn |
| Dec 31, 2022 | 999.51 Mn |
| Dec 31, 2021 | 946.50 Mn |
| Mar 31, 2021 | -388.36 Mn |
| Dec 31, 2020 | 392.55 Mn |
| Dec 31, 2019 | 422.04 Mn |
| Dec 31, 2018 | 309.94 Mn |
| Dec 31, 2017 | 230.32 Mn |
| Dec 31, 2016 | 188.30 Mn |
| Dec 31, 2015 | 229.76 Mn |
| Dec 31, 2014 | 247.39 Mn |
| Dec 31, 2013 | 9.00 Mn |
| Dec 31, 2012 | 133.91 Mn |
| Jun 30, 2012 | 108.44 Mn |
| Dec 31, 2011 | 104.48 Mn |
| Dec 31, 2010 | 96.17 Mn |
| Jun 30, 2010 | 96.44 Mn |
| Dec 31, 2009 | 11,896.30 |